Keywords: Novelos, Cellectar, Cancer compounds, &A, Financing, Solid tumors, Cancer imaging agents

Novelos Thera completes Cellectar buy and $5.1 million financing

Article | 12 April 2011

Print This

USA-based Novelos Therapeutics (OTCBB: NVLT.ob), a developer of novel drugs for the treatment and diagnosis of cancer, says it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in